Literature DB >> 12351679

Metapopulation dynamics and spatial heterogeneity in cancer.

Isabel González-García1, Ricard V Solé, José Costa.   

Abstract

With the advent of drugs targeting specific molecular defects in cancerous cells [Gorre, M. E., et al. (2001) Science 293, 876-880], it is important to understand the degree of genetic heterogeneity present in tumor cell populations and the rules that govern microdiversity in human cancer. Here, we first show that populations with different genotypes in genes influencing cell growth and programmed cell death coexist in advanced malignant tumors of the colon, exhibiting microsatellite instability. Detailed, physical mapping of the diverse populations shows them to be arranged in small, intermingling areas, resulting in a variegated pattern of diversity. Using computational modeling of the experimental data, we find that the coexistence between similar competitors is enhanced, instead of deterred, by spatial dynamics [Hanski, I. (1999) Metapopulation Dynamics (Oxford Univ. Press, New York)]. The model suggests a simple and plausible scenario for the generation of spatial heterogeneity during tumor progression. The emergence and persistence of the patterns of diversity encountered in the tumors can be generated without a need to invoke differences in mutation rates, neutrality of interactions, or separated time scales. We posit that the rules that apply to spatial ecology and explain the maintenance of diversity are also at work in tumors and may underlie tumor microheterogeneity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351679      PMCID: PMC130590          DOI: 10.1073/pnas.202139299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.

Authors:  A Giraud; I Matic; O Tenaillon; A Clara; M Radman; M Fons; F Taddei
Journal:  Science       Date:  2001-03-30       Impact factor: 47.728

2.  Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma.

Authors:  B Baisse; H Bouzourene; E P Saraga; F T Bosman; J Benhattar
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

3.  Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.

Authors:  H Fujii; M Yoshida; Z X Gong; T Matsumoto; Y Hamano; M Fukunaga; R H Hruban; E Gabrielson; T Shirai
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

Review 4.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer.

Authors:  P Peltomäki
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneity.

Authors:  R Barnetson; J Jass; R Tse; R Eckstein; B Robinson; M Schnitzler
Journal:  Genes Chromosomes Cancer       Date:  2000-10       Impact factor: 5.006

6.  Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution.

Authors:  Y Ionov; H Yamamoto; S Krajewski; J C Reed; M Perucho
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

8.  Regional reproducibility of microsatellite instability in sporadic colorectal cancer.

Authors:  W S Samowitz; M L Slattery
Journal:  Genes Chromosomes Cancer       Date:  1999-10       Impact factor: 5.006

9.  Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations.

Authors:  C Waghorne; M Thomas; A Lagarde; R S Kerbel; M L Breitman
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

10.  Genetic heterogeneity and clonal evolution in neuroblastoma.

Authors:  J Mora; N K Cheung; W L Gerald
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

View more
  78 in total

Review 1.  Krüppel cripples prostate cancer: KLF6 progress and prospects.

Authors:  Goutham Narla; Scott L Friedman; John A Martignetti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  Synchronization and entrainment of coupled circadian oscillators.

Authors:  N Komin; A C Murza; E Hernández-García; R Toral
Journal:  Interface Focus       Date:  2010-10-13       Impact factor: 3.906

3.  Label-free direct electronic detection of biomolecules with amorphous silicon nanostructures.

Authors:  John Lund; Ranjana Mehta; Babak A Parviz
Journal:  Nanomedicine       Date:  2006-12       Impact factor: 5.307

4.  Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.

Authors:  David E Joyner; Mark L Wade; Aniko Szabo; Jeffrey Bastar; Cheryl M Coffin; Karen H Albritton; Philip S Bernard; R Lor Randall
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-22       Impact factor: 4.553

5.  Accurate reconstruction of the temporal order of mutations in neoplastic progression.

Authors:  Kathleen Sprouffske; John W Pepper; Carlo C Maley
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

6.  The effect of network topology on the stability of discrete state models of genetic control.

Authors:  Andrew Pomerance; Edward Ott; Michelle Girvan; Wolfgang Losert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-29       Impact factor: 11.205

7.  Putative precursor cancer cells in human colorectal cancer tissue.

Authors:  Teodora E Goranova; Masayuki Ohue; Kikuya Kato
Journal:  Int J Clin Exp Pathol       Date:  2008-07-14

8.  Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.

Authors:  Kejia Cai; He N Xu; Anup Singh; Lily Moon; Mohammad Haris; Ravinder Reddy; Lin Z Li
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

9.  Population genetics of cancer cell clones: possible implications of cancer stem cells.

Authors:  Christopher T Naugler
Journal:  Theor Biol Med Model       Date:  2010-11-09       Impact factor: 2.432

10.  Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing.

Authors:  Katherine E Varley; David G Mutch; Tina B Edmonston; Paul J Goodfellow; Robi D Mitra
Journal:  Nucleic Acids Res       Date:  2009-06-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.